eISSN: 2345-6558

Free Access


Search
Text:  
Field:  

 Editorial pp. 1 - 2  
  An update on sclerostin and kidney
  Hamid Nasri
  PDF      XML      Abstract
 Original pp. 3 - 6  
  Effect and safety of alendronate on bone density in patients with chronic kidney disease; a controlled double blind randomized clinical trial
  Heshmatollah Shahbazian, Mohammad-Reza Tamadon, Seyed Karim Mowla, Shokouh Shayanpour, Fatemeh Hayati, Melika Shojaii, Leila Yazdanpanah
  PDF      XML      Abstract
 Original pp. 7 - 10  
  Correlation of fibroblast growth factor 23 in chronic kidney disease patients with biochemical parameters and outcomes
  Anand Yuvaraj, Georgi Abraham, Madhusudan Vijayan, Jayaraju Jayapal, Saranya Kulanthaipandian, Sanjeev Nair
  PDF      XML      Abstract
 Commentary pp. 11 - 12  
  Fibroblast growth factor 23 and cardiovascular events in chronic kidney disease patients
  Fatemeh Yaghoubi
  PDF      XML      Abstract
 Review pp. 25 - 30  
  Vitamin D and chronic kidney disease
 
  Fatemeh Hayati, Mohammad Amin Nasouti, Shokhouh Shayanpour, Shahla Ahmadi Halili, Hossain Karimpourian, Zarrin Beladi Mousavi
  PDF      XML      Abstract
 Editorial pp. 34 - 35  
  FGF 23 and cardiovascular outcome in chronic kidney disease
 
  Farrokhlagha Ahmadi
  PDF      XML      Abstract
 Original pp. 17 - 24  
  Effectiveness and tolerability of sevelamer in the treatment of hyperphosphatemia in hemodialysis patients
  Usman Kahlid Cheema, Armughan Ahmed, Chaudhary Muhammad Junaid Nazar, Ghias Uddin Butt, Aftab Cheema, Muhammad Bilal, Aisha Ashraf
  PDF      XML      Abstract
 Review pp. 11 - 16  
  Antioxidant efficacy of vitamin D
  Zeinab Mokhtari, Azita Hekmatdoost, Mojgan Nourian
  PDF      XML      Abstract
 Epidemiology and Prevention pp. 1 - 2  
  Fibroblast growth factor 23 and cardiovascular disease in chronic kidney disease; new trends
  Azar Baradaran
  PDF      XML      Abstract      DOI
 Case Report pp. 42 - 44  
  Spontaneous bilateral femoral neck fracture in a man with end-stage renal disease and severe secondary hyperparathyroidism
  Soraya Doustmohamadian, Majid Foroutan
  PDF      XML      Abstract      DOI
 Epidemiology and Prevention pp. 5 - 6  
  Challenging look at therapeutic trend of chronic kidney disease–mineral bone disorder in children
  Afshin Safaei-Asl
  PDF      XML      Abstract      DOI
 Review pp. 36 - 38  
  The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder
  Ramin Tolouian, Ajay Gupta
  PDF      XML      Abstract      DOI
 Original pp. 50 - 56  
  Bone mineral density and bone metabolism biochemical markers in patients with chronic kidney disease at the hemodialysis treatment
  Mohammad Reza Tamadon, Jamileh Moghimi, Vahid Semnani
  PDF      XML      Abstract      DOI
 Original pp. 57 - 63  
  Relationship of bone density with serum parathyroid hormone in hemodialysis patients; a single center study
  Bita Omidvar, Ali Ghorbani, Mohammad Reza Tamadon, Zahra Sadeghian Broujeni
  PDF      XML      Abstract      DOI
 Case Report pp. 68 - 71  
  Superior vena cava syndrome complicating calcific uremic arteriolopathy in an ESRD male patient on maintenance hemodialysis following failed kidney transplantation
  Macaulay Amechi Chukwukadibia Onuigbo, Nneoma Agbasi, Abdul Khan, Vinay Nijhawan, Zhibin Jiang
  PDF      XML      Abstract      DOI
 Commentary pp. 72 - 73  
  Magnesium and parathyroid hormone among end-stage renal disease patients
  Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Shokouh Shayanpour, Shahla Ahmadi Halili
  PDF      XML      Abstract      DOI
 Brief Communication pp. 64 - 67  
  Secondary hyperparathyroidism among end-stage renal disease patients in Beharlou hospital, Tehran province, Iran
  Seyed Majid Mousavi Movahed, Seyed Seifollah Beladi Mousavi, Mohammad Faramarzi
  PDF      XML      Abstract      DOI

Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute